INTEGRA LIFESCIENCES HOLDINGS CORP - Common Stock (IART)

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / Common Stock
Shares outstanding
77,575,733
Number of holders
276
Total 13F shares, excl. options
68,833,788
Shares change
-3,850,136
Total reported value, excl. options
$2,831,315,238
Value change
-$177,674,783
Put/Call ratio
8.9%
Number of buys
131
Number of sells
-151
Price
$41.13

Significant Holders of INTEGRA LIFESCIENCES HOLDINGS CORP - Common Stock (IART) as of Q2 2023

326 filings reported holding IART - INTEGRA LIFESCIENCES HOLDINGS CORP - Common Stock as of Q2 2023.
INTEGRA LIFESCIENCES HOLDINGS CORP - Common Stock (IART) has 276 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 68,833,788 shares of 77,575,733 outstanding shares and own 89% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (7,087,560 shares), BlackRock Inc. (6,775,449 shares), MORGAN STANLEY (6,256,003 shares), Champlain Investment Partners, LLC (3,901,723 shares), WELLINGTON MANAGEMENT GROUP LLP (3,357,762 shares), Capital Research Global Investors (3,258,146 shares), ALLIANCEBERNSTEIN L.P. (2,876,528 shares), Clearbridge Investments, LLC (2,760,594 shares), COOKE & BIELER LP (2,739,654 shares), and STATE STREET CORP (2,217,605 shares).
This table shows the top 276 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.